top of page
Updates
News, milestones, and insights from NeutroGen Therapeutics. Follow our journey as we develop innovative neutrophil-based therapies to address critical unmet medical needs in oncology and infectious diseases.
Press Contact
ADDRESS
NeutroGen Therapeutics GmbH
c/o Bayer AG, Co.Labs (S107/11)
Müllerstraße 178
DE-13353 Berlin
CONTACT Person
Holger Münchmeyer
contact@neutrogen-therapeutics.com
bottom of page





